These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3539793)

  • 1. An orally active inhibitor of renin.
    Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
    Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and renal haemodynamic effects of renin or angiotensin converting enzyme inhibition in non-human primates.
    Pals DT; Ludens JH; DeGraaf GL
    J Hypertens Suppl; 1989 Apr; 7(2):S43-6. PubMed ID: 2666613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeys.
    Thaisrivongs S; Pals DT; DuCharme DW; Turner SR; DeGraaf GL; Lawson JA; Couch SJ; Williams MV
    J Med Chem; 1991 Feb; 34(2):633-42. PubMed ID: 1995887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
    Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
    J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
    Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
    J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of a renin inhibitor in relation to posture in nonhuman primates.
    Pals DT; DeGraaf GL; Kati WM; Lawson JA; Smith CW; Skala GF
    Clin Exp Hypertens A; 1985; 7(1):105-21. PubMed ID: 2986882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
    Pals DT; DeGraaf GL; Couch SJ; Brunden MN
    Clin Exp Hypertens A; 1991; 13(3):425-36. PubMed ID: 1893613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin inhibition in the conscious primate Macaca fascicularis.
    Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
    Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the inhibition of human renin by an inhibitor containing a hydroxyethylene dipeptide isostere.
    Kati WM; Pals DT; Thaisrivongs S
    Biochemistry; 1987 Dec; 26(24):7621-6. PubMed ID: 3322403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat model for evaluating inhibitors of human renin.
    Pals DT; Lawson JA; Couch SJ
    J Pharmacol Methods; 1990 Jul; 23(4):239-45. PubMed ID: 2196401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.
    Kleinert HD; Martin D; Chekal MA; Kadam J; Luly JR; Plattner JJ; Perun TJ; Luther RR
    Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
    Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
    Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.
    De Claviere M; Cazaubon C; Lacour C; Nisato D; Gagnol JP; Evin G; Corvol P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S58-61. PubMed ID: 2412015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys.
    Takaori K; Hartley LH; Burton J
    Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRI-1314: an orally effective inhibitor of human renin.
    Etoh Y; Miyazaki M; Saitoh H; Toda N
    Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs.
    Blaine EH; Schorn TW; Boger J
    Hypertension; 1984; 6(2 Pt 2):I111-8. PubMed ID: 6373590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different drug interference with the renin-angiotensin system.
    Hofbauer KG; Fuhrer W; Heusser C; Wood JM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S62-8. PubMed ID: 2412016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ro 42-5892 is a potent orally active renin inhibitor in primates.
    Fischli W; Clozel JP; el Amrani K; Wostl W; Neidhart W; Stadler H; Branca Q
    Hypertension; 1991 Jul; 18(1):22-31. PubMed ID: 1830563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.